1. Home
  2. CHMI vs LUNG Comparison

CHMI vs LUNG Comparison

Compare CHMI & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.90

Market Cap

108.3M

Sector

Real Estate

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.86

Market Cap

97.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMI
LUNG
Founded
2012
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Industrial Specialties
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.3M
97.1M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
CHMI
LUNG
Price
$2.90
$1.86
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$3.00
$5.38
AVG Volume (30 Days)
293.1K
395.5K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
15.09%
N/A
EPS Growth
N/A
7.64
EPS
N/A
N/A
Revenue
N/A
$90,497,000.00
Revenue This Year
N/A
$2.48
Revenue Next Year
$61.13
$18.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.01
52 Week Low
$2.17
$1.13
52 Week High
$3.04
$2.89

Technical Indicators

Market Signals
Indicator
CHMI
LUNG
Relative Strength Index (RSI) 63.93 38.64
Support Level $2.55 $1.20
Resistance Level $2.98 $2.49
Average True Range (ATR) 0.04 0.15
MACD -0.02 -0.08
Stochastic Oscillator 6.25 7.74

Price Performance

Historical Comparison
CHMI
LUNG

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: